ROSA DAVID A (CEO and President) received a stock award from NEUROONE MEDICAL TECHNOLOGIES CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/21/2024ACC: 0001540354-24-000002
DirectorOfficer· CEO and President
Since Feb 2026
+663.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
663.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+663.50K
Price / share
—
Trade value
—
% of position
126.3%
2/18/2024
525.49K→1.19M
Total
Net shares
+663.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2024 | A · Award | +663.50K | — | — | 126.3% | 525.49K | 1.19M |
| Total | +663.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported